Molecular docking demonstrated potential interactions of sevoflurane and propofol with MMP9 and HPSE.<h4>Conclusion</h4>These findings provide novel insights into the potential association between exposure to sevoflurane and propofol and the progression of T2DM, and identify candidate therapeutic targets. Here, MMP9 is linked to type 2 diabetes mellitus.